290 related articles for article (PubMed ID: 9427279)
1. The pharmacoeconomics of cancer therapies.
Bishop JF; Macarounas-Kirchman K
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-106-S19-111. PubMed ID: 9427279
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectivenes of paclitaxel plus cisplatin in advanced non-small-cell lung cancer.
Earle CC; Evans WK
Br J Cancer; 1999 May; 80(5-6):815-20. PubMed ID: 10360660
[TBL] [Abstract][Full Text] [Related]
3. A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.
Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-5-S17-9. PubMed ID: 9374084
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and carboplatin for advanced breast cancer.
Perez EA; Hartmann LC
Semin Oncol; 1996 Oct; 23(5 Suppl 11):41-5. PubMed ID: 8893899
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the costs of paclitaxel and best supportive care in stage IV non-small-cell lung cancer.
Earle CC; Evans WK
Cancer Prev Control; 1997 Oct; 1(4):282-8. PubMed ID: 9765752
[TBL] [Abstract][Full Text] [Related]
6. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
Hainsworth JD; Greco FA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
8. Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.
Seidman AD; Hudis CA; Fennelly D; Raptis G; Baselga J; Norton L
Semin Oncol; 1995 Oct; 22(5 Suppl 12):108-16. PubMed ID: 7481852
[TBL] [Abstract][Full Text] [Related]
9. Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
Bunn PA
Semin Oncol; 1996 Dec; 23(6 Suppl 15):9-15. PubMed ID: 8996590
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD
Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
[TBL] [Abstract][Full Text] [Related]
11. Future developments for paclitaxel in the treatment of breast cancer.
Bonadonna G
Semin Oncol; 1996 Feb; 23(1 Suppl 1):65-8. PubMed ID: 8629041
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma. A lifetime cost-effectiveness analysis.
Messori A; Trippoli S; Becagli P; Tendi E
Cancer; 1996 Dec; 78(11):2366-73. PubMed ID: 8941008
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.
Buzdar AU; Hortobagyi GN; Asmar L; Theriault RL; Rahman Z; McNeese M; Singletary S; Ames F
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-31-S17-34. PubMed ID: 9374089
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel via 1-hour infusion: clinical experience.
Greco FA; Hainsworth JD
Semin Oncol; 1996 Dec; 23(6 Suppl 16):91-3. PubMed ID: 9007131
[TBL] [Abstract][Full Text] [Related]
16. Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma?
Covens A; Boucher S; Roche K; Macdonald M; Pettitt D; Jolain B; Souetre E; Rivière M
Cancer; 1996 May; 77(10):2086-91. PubMed ID: 8640674
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy in the management of patients with inoperable non-small cell lung cancer.
Carney DN
Semin Oncol; 1996 Dec; 23(6 Suppl 16):71-5. PubMed ID: 9007127
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of paclitaxel in combination with cisplatin for patients with advanced ovarian cancer.
Ortega A; Dranitsaris G; Sturgeon J; Sutherland H; Oza A
Gynecol Oncol; 1997 Sep; 66(3):454-63. PubMed ID: 9299261
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer.
Ozols RF
Semin Oncol; 2000 Jun; 27(3 Suppl 7):3-7. PubMed ID: 10952119
[TBL] [Abstract][Full Text] [Related]
20. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
Hudis CA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
